PCSS Half & Half Waiver Training
Half & Half Waiver Training
Prescribing Buprenorphine for the Treatment of
Opioid Use Disorder
Audience
Physicians, Advanced Practice Registered Nurses, Physician Assistants
We also offer this course specialized for Emergency Medicine prescribers.
Training Overview
The PCSS Half-and-Half Waiver Training course provides an overview of the FDA-approved medication buprenorphine prescribed for the treatment of opioid use disorder (OUD). The course meets the 8-hour training to prescribe buprenorphine for the treatment of OUD. The course trainer will conduct an overview of prevention, identification, and treatment of substance use disorders emphasizing OUD.
- For eligible prescribers interested in treating more than 30 patients: register for one of our upcoming waiver trainings
The 8-hour buprenorphine waiver training is offered in a ‘half- and-half’ format - 4 hours of in-person or virtual training followed up by 4 hours of online training through PCSS. Upon completion of the training, providers will meet the requirement of DATA 2000 to apply for a waiver to prescribe buprenorphine for more than 30 patients.
- Physicians complete the standardized buprenorphine waiver 8-hour training.
- Advanced Practice Registered Nurses and Physician Assistants complete the standardized buprenorphine waiver 8-hour training as well as an additional 16 hours of online training as established by the Comprehensive Addiction and Recovery Act (CARA) which can be found here: https://pcssnow.org/medications-for-opioid-use-disorder/
New HHS practice guidelines from the Department of Health and Human services make providing life-saving treatment for opioid use disorder easier.
- For eligible prescribers interested in treating 30 patients or less: Sign up for your waiver
Learning Objectives
- Review addiction treatment in office-based practices
- Discuss the pharmacological treatments of opioid use disorder
- Determine what medical record documentation must be followed
- Discuss the process of buprenorphine induction as well as stabilization and maintenance techniques
- Describe how to take a patient history and evaluation
- Review safety concerns and drug interactions
Bring this training to your organization or region:
Visit our upcoming trainings page or contact MACSTraining@som.umaryland.edu for more information.
Still unsure?
Learn more about obtaining your waiver to prescribe buprenorphine. Attend our training on Understanding the Opioid Epidemic: Providers’ Role in the Treatment of Opioid Use Disorder.
American Academy of Addiction Psychiatry (AAAP) is the Data 2000 Sponsor for this training.
Funding for this initiative was made possible (in part) by grant no. 1H79TI081968 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
The Maryland Addiction Consultation Service is administered by the University of Maryland School of Medicine and funded by the Maryland Department of Health, Behavioral Health Administration.